Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panmure Gordon was a historic UK-based investment bank founded in 1876 that provided investment banking services—including corporate finance advisory—to many sectors such as healthcare and life sciences but was never itself a biotech/pharma/life science company. It acted as nominated adviser/broker for several biopharmaceutical firms' financings but did not develop drugs or own therapeutic platforms. In July 2024 it merged with Liberum Capital to become "Panmure Liberum", ceasing its existence as an independent brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panmure Gordon.